Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze
暂无分享,去创建一个
[1] R. Russell,et al. Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP. , 1974, Pharmacology, biochemistry, and behavior.
[2] G. Lunt,et al. Presynaptic modulation of transmitter release by nicotinic receptors. , 1989, Progress in brain research.
[3] P. Rowell,et al. Nicotinic Stimulation of [3H]Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes , 1984, Journal of neurochemistry.
[4] M. E. Goldberg,et al. Learning impairment after three classes of agents which modify cholinergic function. , 1971, Archives internationales de pharmacodynamie et de therapie.
[5] E. T. Iwamoto. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. , 1989, The Journal of pharmacology and experimental therapeutics.
[6] P. Whitehouse. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. , 1987, Advances in neurology.
[7] E. Levin,et al. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. , 1990, Behavioral and neural biology.
[8] Bengt Winblad,et al. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains , 1986, Neuroscience Letters.
[9] L. Jarrard,et al. Scopolamine impairs performance of a place and cue task in rats. , 1982, Behavioral and neural biology.
[10] L. Butcher,et al. Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. , 1989, Behavioral and neural biology.
[11] L. Ferraro,et al. Effect of nicotine on the release of acetylcholine and amino acids in the brain. , 1989, Progress in brain research.
[12] R. Stevens. Scopolamine impairs spatial maze performance in rats , 1981, Physiology & Behavior.
[13] Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. , 1969, Archives internationales de pharmacodynamie et de therapie.
[14] J. Coyle,et al. Nicotinic acetylcholine binding sites in Alzheimer's disease , 1986, Brain Research.
[15] L. Butcher,et al. Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. , 1990, Behavioral and neural biology.
[16] R. Beninger,et al. Differential effects of scopolamine on working and reference memory of rats in the radial maze , 1984, Pharmacology Biochemistry and Behavior.
[17] E. Levin. Psychopharmacological effects in the radial-arm maze , 1988, Neuroscience & Biobehavioral Reviews.
[18] S. L. Dilts. Berry CA: Effect of cholinergic drugs on passive avoidance in the mouse. , 1967, The Journal of pharmacology and experimental therapeutics.
[19] B. Martin,et al. What is the nature of mecamylamine's antagonism of the central effects of nicotine? , 1989, Biochemical pharmacology.
[20] A. Oliverio. Effects of mecamylamine on avoidance conditioning and maze learning of mice. , 1966, The Journal of pharmacology and experimental therapeutics.
[21] E. Levin,et al. Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. , 1990, Behavioural pharmacology.
[22] J. Sirviö,et al. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning , 1990, Pharmacology Biochemistry and Behavior.
[23] R. Stevens,et al. Effects of scopolamine on radial maze performance in rats , 1981, Physiology & Behavior.
[24] E D Levin,et al. Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. , 1987, Behavioral and neural biology.